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S. aureus is aerobic, catalase-positive, and oxidase negative organism, and present in the 
normal microbial flora of the upper respiratory tract and the skin without causing any disease, 
but at the same time as a potential humans pathogen. S. aureus adheres to the host tissues by 
means of microbial surface components recognizing adhesive matrix molecules 
(MSCRAMMs).  
SdrD is one of three-sdr family proteins, which plays a role in adherence to human nasal 
epithelial cells. It is assumed that the A-domain of SdrD interacts with a host protein, which is 
not yet identified.  
The aim of this study was to investigate whether there is allelic variation in sdrD gene among 
S. aureus isolates from healthy carriers in Tromsø 6 study and to determine if the sdrD 
variants differ in their adherence ability to selected human interaction partners. 
DNA from 51 S. aureus isolates was extracted, and the A-region of sdrD was amplified, 
purified and the products were sequenced. The sdrD sequences were aligned, and the 
identities of the sequences were checked using BLAST. 
To evaluate the contribution of sdrD variants in adhesion, a standard cloning method was 
used. A full-length sdrD variant was cloned into a shuttle vector and transformed into E. coli 
then into the gram-positive surrogate host L. lactis. 
The finding from this study indicates that there is allelic variation in sdrD A-region among S. 
aureus. From a total of 51 clinical isolates; six different sdrD variants were revealed. Full-
length SdrD1 variants was cloned into a shuttle vector and transformed into E. coli. The 
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1. Introduction    
1.1 Staphylococcus aureus  
	  
Staphylococcus aureus (S. aureus) is a non-sporulation gram-positive bacterium, which 
belongs to a bacterial genus staphylococcaceae. It divides in several planes to form irregular 
clumps, and this form of arrangement helps to differentiate staphylococci from streptococci. 
On microscopic examination, this organism is 0.5 to 1.5 um in diameter. It occurs singly, in 
pairs, as short chains, or in grapelike clusters. S. aureus is typically hemolytic and forms 
pigmented yellow-orange colonies on blood agar. S. aureus is aerobic, catalase-positive, and 
oxidase negative organism. This bacterium is present in the normal microbial flora of the 
upper respiratory tract and the skin without causing any disease but at the same time it is a 
potential humans pathogen. (Todar, 2008-2012) 
 
1.2 Colonization of S. aureus 
	  
S. aureus cells can survive for months on any type of surface (Crossley and Archer, 1997).  
S. aureus colonizes the skin and mucosae of humans and several animal species. Multiple 
body sites can be colonized in humans, but the anterior nares of the nose are the most 
frequently colonized site by S. aureus. (Williams, 1963)  
Humans carry S. aureus without symptoms that make prevention of S. aureus infections 
difficult. Studies show that about 20% of individuals are persistent nasal carriers, 30% are 
intermittent carriers, and about 50% non-carriers. (Kluytmans et al., 1997, Nouwen et al., 
2004)  
Individuals who carry S. aureus are in a higher risk for getting S. aureus infections and to 
transmit the bacteria to healthy individuals or patients. The risk of infection in intermittent 
carriers and non-carriers is similar. Patients often acquire S. aureus from healthcare personnel 
who are asymptomatic carriers. Carriers are often infected by their own strain carried in the 
nose. (White, 1963, Nouwen et al., 2005) 
Adherence of S. aureus is one of critical steps for colonization. Colonization of S. aureus is 
multifactorial and determined by host and bacterial factors. (Weidenmaier et al., 2012) For 
example, individuals with HIV infection, intravenous drug users, diabetics, hemodialysis 
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patients, cystic fibrosis patients and hospitals inpatients have a high rates of colonization (Ten 
Broeke-Smits et al., 2010). 
 
1.3 Pathogenesis of S. aureus 
	  
Ogston discovered Staphylococcal disease, the role of S. aureus in sepsis and abscess 
formation in 1880 (Ogston, 1882) however, S. aureus is still the second most common 
pathogen isolated and is remained to be a difficult and dangerous pathogen to treat in humans 
(Fehrmann et al., 2013). 
S. aureus causes diseases such as acne, boils, phlebitis, impetigo, and many of these diseases 
cause the production of pus. It also causes life-threating pneumonia, osteomyelitis, 
endocarditis, meningitis, mastitis, urinary tract infections, arthritis, toxic shock syndrome 
(TSS) and food poisoning; (Todar, 2008-2012) resulting in considerable global human 
morbidity and mortality (Lowy, 1998). 
S. aureus was isolated in 1880, and was sensitive to penicillin until 1946. While S. aureus 
developed resistance against penicillin, the new type of penicillin, Methicillin was arrived in 
1959. It took only 2 years, before S. aureus was able to resist methicillin. Methicillin 
resistance S. aureus (MRSA) was identified in 1961 and responded only to very advanced 
antibiotics that were not meant to be the first-line treatment. Several studies have shown that 
the prevalence of MRSA varies geographically. The highest rates reported in Sri-lanka 86.5 % 
while in European countries especially in Netherland and Scandinavian the rate is less than 
1%. (Stefani et al., 2012) 
 
How can S. aureus overcome host defense? 
 
S. aureus provides various strategies to escape from the host immune response. These 
strategies involve several types of enterotoxins and exotoxin that help to overcome a host’s 
defense. In addition, S. aureus is able to resist certain cationic antimicrobial peptides by 
reducing the net negative charge of its cell wall and cell membrane. (Peschel, 2002)  
Another method is that S. aureus neutralizes the killing mechanism of phagocytic cells by 
producing carotenoids and catalase (Van Belkum et al., 2002). 
 
	   3	  
 
 How S. aureus adhere to the host cell? 
 
Colonization is one of the risk factor for infection. The key step for colonization is adherence. 
In order to colonize, S. aureus must adhere to the host cell and overcome host defense. 
(Johannessen et al., 2012, McCarthy and Lindsay, 2010, Vengadesan and Narayana, 2011)  
S. aureus adheres to host cells by binding directly to epithelial cells, by invading sites of 
cellular damage, by migrating between endothelial cells and by bridging ligands (Lowy, 
2000).  
In a recent study, Triclosan that is used for over 40 years in personal care products and 
medical equipment’s (soaps, toothpastes, catheters) to prevent infections was to promote nasal 
colonization of S. aureus (Syed et al., 2014). In another study, Staphylococcal H35A α-toxin 
was shown to inhibit adherence of S. aureus (Yang et al., 2013). These studies are examples 
demonstrating how complicated the adherence of S. aureus to the host can be. 
 
1.4 Cell-wall glycopolymer (CWG) 
	  
Gram-positive bacterial cell-wall contains peptidoglycan (Brown et al., 2013) and 
glycopolymers. Cell-wall glycopolymers (CWG) binds non-covalently to cell wall proteins. 
CWG are strain specific with variable structures and they have role in adhesion, virulence and 
assumed to prevent opsonization. CWG mutant S. aureus reduced biofilm formation. 
(Weidenmaier and Peschel, 2008) 
 
 Wall teichoic acid (WTA) 
 
Wall teichoic acid (WTA) and lipoteichoic (LTA) acid are zwittrionic cell-wall polymer 
(Reichmann and Grundling, 2011).  
WTA was discovered in 1950 and it is one of cell-wall glyco-polymers of gram-positive 
bacteria. It binds S. aureus to epithelial and endothelial cells and is assumed that it is essential 
for nasal colonization. (Weidenmaier et al., 2004) 
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WTA facilitates adhesions of S. aureus to the inner nasal cavity. Charged amino acids in 
WTA are responsible for this reaction. (Baur et al., 2014)  
Studies showed that WTA mutant, that is lacks D-alanine is not capable of adhering to cotton 
rat nares (Weidenmaier and Peschel, 2008). WTA mutant bacteria were grow slower, 
sensitive to high temperature and unable to grow in high salt media. By altering bacterial cell 
surface, WTA play a role of protecting bacteria from antibiotics and host defense. (Brown et 
al., 2013) 
 
Lipoteichoic acid (LTA) 
 
LTA is bound to the bacterial membrane via glycolipid (Brown et al., 2013) and have a 
crucial part in cell division. It activates human Toll-like receptor TLR2 (receptor which 
recognizes pathogens). LTA is essential for the survival S. aureus. (Grundling and 
Schneewind, 2007) 
 LTA mutant S. aureus showed defects in biofilm formation and reduced ability to adhere 
(Fedtke et al., 2007). 
 
1.5 Microbial Surface Components Recognizing Adhesive Matrix Molecules 
(MSCRAMMS) 
 
There are 22 proteins that are covalently attached to the cell wall of S. aureus by sortase A or 
B. Six proteins are ionic attached and one protein is attached trans-membrane (Mazmanian et 
al., 2002). Even though the mode of attachments is known, ligand specificity of the most of 
proteins has not been determined. 
In addition, S. aureus adheres to host tissues by using its microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs). MSCRAMMs recognize fibronectin, 
fibrinogen, collagen, and heparin related polysaccharides. They are responsible for the initial 
contact with host cells. (Patti et al., 1994) 
MSCRAMMs are bound to the cell-wall peptidoglycan covalently, ionic and trans-membrane, 
but most of them are bounded covalently (Clarke and Foster, 2006). 
	   5	  
MSCRAMMs are proteins that have adhesive properties such as, protein A (Spa), iron 
regulated surface determinant protein A (IsdA), serine-aspartate repeat-encoding protein 
(SdrC, SdrD and SdrE), collagen binding protein (Cna), Fibronectin binding protein A and B 
(FnBPA and FnBPB), clumping factor A and B (ClfA anf ClfB) and S. aureus surface protein 
G (SasG). (Foster and hook 1998; (Josefsson et al., 1998, Foster et al., 2014) 
MSCRAMMs are a family of proteins that have the same structural organization (Figure 1) 
and a common mechanism for ligand binding. MSCRAMMs can bind to two or more ligands 
and are found in Staphylococcus psedintermedius, Coagulase negative Staphylococci, 
Entrococci and Streptococci. MSCRAMMs act as a virulence factor and are important in 
pathogenesis. (Foster et al., 2014) 
Clf-Sdr protein family 
S N1 N2 N3 SD-repeats W M 
FnBPs 
S N1 N2 N3 FnBP- repeats W M 
Cna 
S N1 N2 N3 B B B W M 
NEAT motif family (IsdA & IsdB) 
S NEAT C W M 
Three-helical bundle family (Spa) 
S E A B C D Xr Xc M 
G5-E repeats family (SasG) 
S A G5 E G5 E G5 E G5 E G5 E G5 E W M 
Figure 1: An image illustrates structural organization of MSCRAMMs. Clf-Sdr(Clumping 
factor Ser-Asp repeat protein), FnBPs (Fibronectin-binding proteins), Can (collagen binding 
protein), NEAT(Near iron transporter motif protein family(IsdA & IsdB), Spa (S. aureus 
protein A) SasG (S. aureus surface protein G). “S “represents signal sequences, “W” 
represents cell wall-spaning region and “M” sorting signal. Modified from (Foster et al., 
2014). 
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1.5.1 S. aureus Protein A (Spa) 
	  
Spa is a surface protein of S. aureus which binds both von Willebrand factor (vWF) (Hartleib 
et al., 2000) and Tumour-Necrosis Factor-α (TNFRα) (Gomez et al., 2004). vWF are a large 
multimeric serum glycoprotein that mediates platelet adhesion at site of endothelial damage. 
TNFRα is a receptor for tumour-necrosis factor-α. In addition, Spa binds IgG molecules in a 
wrong orientation on their surface and that helps the bacterium avoid opsonization and 
phagocytosis. (Todar, 2008-2012) 
 Spa has a role in the pathogenesis of endovascular diseases by binding vWF (Hartleib et al., 
2000). 
 
1.5.2 The Ser-Asp dipeptide repeats (Sdr) family of proteins 
	  
S. aureus Sdr proteins have a potential adhesion function, which are involved in adherence to 
epithelial cells and contain putative B-domains (Lowy, 1998, Josefsson et al., 1998).  
Sdr is derived from a repetition of amino acid serine –S- and aspartic acid –D. They are 
MSCRAMMs proteins involved in adherence to epithelial cells. (Corrigan et al., 2009) 
The Sdr families in S. aureus are encoded sdrC, sdrD and sdrE genes (Josefsson et al., 1998), 
and the Sdr families in S. aureus epidermids are encoded sdrG, sdrF and sdrH  (McCrea et 
al., 2000).   
Sdr-families are structurally related to a family of cell wall anchored proteins known as ClfA 
and ClfB, with the exception of an additional B repeat domain of unknown function (Figure 
2) (Josefsson et al., 1998). 
SdrD has five tandem repeats (B5), while SdrC has two (B2) and SdrE has three (B3). The 
amino acid sequence identity of B2 with B5 is 97%; B2 with B3 and B3 with B5 is 94% 
similar. (Becherelli et al., 2013) 
Signal sequence peptide (S), which is 75-90% similar among the sdr- families followed by a 
putative extracellular matrix (ECM) binding segment. A-region is identical with only 20-30% 
amino acid residues among the three members of the Sdr families. The A-region is followed 
by B-repeats. Ser-Asp residues dipeptides (R region) differentiate the Sdr families from ClfA 
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and ClfB. C-terminal to R-region is 83-97% identical among the Sdr families. (Josefsson et 
al., 1998) 
 
1.5.2.1 Ser-Asp dipeptid repeats-D (SdrD) protein 
	  
SdrD is one of three-sdr family proteins, which plays a role in adherence to human nasal 
epithelial cell (Corrigan et al., 2009). The similarity of amino acids sequence identity between 
SdrC and SdrD is 34 %, and 43% between SdrD and SdrE (Becherelli et al., 2013).  
The ribosome-binding sequences similarity of SdrD with SdrC and SdrE are 54% and 75%, 
respectively. In addition, 369 bp differentiates SdrD from SdrC, while 397 bp differentiates 
SdrD from SdrE. The other difference between SdrD and Sdr families is B-motifs. The A-
region is divided into three sub-domains, which are named as N1, N2 and N3 (see Figure 2). 
There is 20-30% amino acid sequence similarity of the N domain between Sdr families. 
(Wang et al., 2013, Josefsson et al., 1998) 
The expression level of SdrC, SdrD and SdrE during bacterial growth phase is different. SdrD 
expression is highest in early logarithmic growth phase, decreases in the mid logarithmic 
phase, and stays low until the stationary growth phase. Expression of SdrC and SdrE is 
similar. These are expressed in all growth phases and their expression declines in the 
stationary growth phase, but the difference between early logarithmic phase and stationary 
phase for SdrE is greater than for SdrC.(Sitkiewicz et al., 2011)  
 
SdrC   445aa 
S N1 N2 N3 B B R W M 
 
SdrD  516aa 
S N1 N2 N3 B B B B B R W M 
 
SdrE  554aa 
S N1 N2 N3   B B    B         R W M 
Figure 2: Structural organization of staphylococcal Sdr proteins families modified 
from(Josefsson et al., 1998) .S represents signal sequences，N1, N2, N3, represent putative 
ligand-binding in A region, B, represent B repeat, R represents the Ser-Asp dipeptide repeats, 
W represents cell wall-spaning segments and M represents membrane-spanning regions and 
positively charged residues. A-region of SdrD has 445 Amino acids, SdrD has 516 amino 
acids and sdrE has 554 amino acids. 
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1.5.2.2 The Fibronectin-binding proteins (FnbpA and FnbpB)  
	  
The Fibronectin-binding proteins are encodes by FnbA and FnbB. The two genes are closely 
linked but transcribed separately (Greene et al., 1995). The A-domain of FnbpA and FnbpB is 
45% identical. It also shares 25% identity to the A-domain of ClfA and ClfB. The FnbpA and 
FnbpB A domains bind to the C terminus of the γ-chain of fibrinogen at the same site as ClfA 
and the platelet integrin. (Wann et al., 2000) 
Fibronectin-binding proteins FnbpA and FnbpB bind to fibrinogen and elastin as well as to 
Fibronectin (Roche et al., 2004). FnBp binds to the host protein Fibronectin that bridges the 
bacteria to host receptor named integrins on the cell surface (Figure 3)(Foster, 2002). Elastin 
is a hydrophobic protein that provides resilience and elasticity to tissues such as lung, aorta, 
and skin. Tropoelastin is a soluble precursor of elastin, which is produced by smooth muscle 






















α 5β 1-integrin 
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1.5.2.3 Clumping factor A and B (ClfA and Clf B) 
	  
ClfA and ClfB are members of a family of proteins that are covalently anchored to the cell 
wall peptidoglycan. ClfA of S. aureus binds to the Fibrinogen (Fg) γ-chain in the blood. ClfB 
binds to the α-chain of fibrinogen as well as to cytokeratin 10. The key difference between 
ClfA and ClfB is that ClfA binds to the C terminus of the Fg γ-chain, whereas ClfB binds to 
the Fg α-chain at a site that is flanked by many residues on either side of the binding region. 
(Ponnuraj et al., 2003) 
The other difference of ClfA and ClfB is that they are present in bacteria in different stages of 
growth phases. ClfA is present in all stages of growth, while ClfB is found in early 
exponential phase and is absent in stationary phase. (Foster and Hook, 1998) 
ClfA subdomains N2N3 (Figure 1) are promote fibrinogen binding. The subdomain N1 is 
required for ClfA to be expressed and localized to the S. aureus cell wall. (McCormack et al., 
2014)  
Fg is a 340-kDa glycoprotein that is found at a concentration of around 9 µM in the blood. It 
is composed of six polypeptide chains, two α-, two β-, and two γ-chains, which are arranged 
in a symmetrical di-meric structure. Fg is an important clotting protein that participates in 
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2.  Aim of the study 
	  
Increasing bacterial resistance to almost all available antibiotics causes an urgent need for 
new antimicrobial drugs, drug targets and therapeutic concepts (Høiby, 2000). In order to 
obtain future targets for prevention and therapy, it is important to increase the understanding 
of the molecular aspects of interaction between S. aureus and the host cells.  
Bacterial surface proteins are important to the success of bacterial strains survival (Papa et al., 
2013) therefore they are novel candidates for the development of new antimicrobial drugs or 
vaccines. The combined vaccines with IsdA, IsdB, SdrD and SdrE have produced partial 
protection against S. aureus in vivo animal model, but failed in clinical trial (Stranger-Jones et 
al., 2006). 
The aim of this study is to evaluate whether there is allelic variation in sdrD gene among S. 
aureus isolated from healthy carriers in Tromsø 6 study and to determine if the sdrD variants 
differ in their adherence ability to host cells. 
To determine the contribution of sdrD variants in adhesion, a standard cloning method will be 
used, where full-length sdrD variants will be cloned into the shuttle vector and transformed 
into the gram-positive surrogate host Lactococcus lactis (L. lactis). Thereafter adhesions 
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3. Materials  
 
3.1 Bacterial isolates 
	  
A total of 51 S. aureus isolates were included and an overview of isolates described in 
Appendix 1.  
The bacterial isolates used in this study were from Tromsø 6 study. The Tromsø 6 study was 
the multipurpose population based study and carried out from 2007-2008.  The study included 
12,984 men and women aged 30-87. A total of 4026 men and women aged 30-49 years had a 
nasal swab taken. (Olsen, 2013) 
Among the S. aureus isolates from the Tromsø 6 study, 554 were scanned for sdrD and 28.88 
% were positive while 71.2 % were negative (unpublished results from research group). We 
simply took the first 51 on the list who were sdrD positive. The number 51 is easy to manage 
for our study. 
E. coli strain DH5 and L. lactis strain M1363 competent cells were used for preparing 
competent cells in this study.  
 
3.1.2 sdrD reference strains 
	  
S. aureus  NCTC8325 and S. aureus  MSSA476 were used as control strains for optimization 
of PCR. The sdrD DNA sequences and amino acid sequences from S. aureus strains 
NCTC8325 (Acc.nr.NC_007795.1), MSSA476 (Acc.nr.NC_002953.3), N315 
(Acc.nr.NC_002745.2), Ho50960412 (Acc.nr.NC-017763.1), MW2 (Acc.nr.NC_003923.1) 
and Newman (Acc.nr.NC_009641.1) were used as reference sequences in alignment. 




Two different pMG36e plasmids were used; one pMG36e plasmid containing SdrD from S. 
aureus strain NCTC8325 (pMG36e:SdrD_NCTC8325) and  one “empty plasmid” pMG36e 
without sdrD. These were kindly provided by Professor Dzung Bao Diep Norwegian 
University of life sciences, Ås (NMBU) (Figure 4 and Figure 5).  
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Figure 4: Cloning vector pMG36e containing SdrD from S. aureus strain NCTC8325 
(pMG36e:sdrD_NCTC8325)  (professor DB. Diep, 2012) 
 
 
Figure 5: Cloning vector Empty pMG36e. pMG36e vector without sdrD (professor DB. 
Diep, 2012) 
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3.3 Primers, materials, chemicals and reagents  
Table 1: List of primers  
 Manufa
cturer 
Sequence (5’-3’) Reference 
SdrD-A-F Sigma GGAACCAAGAAGCAAAGGCTG (Xue et 
al., 2011) 
SdrD-A-R Sigma CTTCTTGACCAGCTCCGCCAC (Xue et 
al., 2011) 
SdrD-forw Sigma AGTTGATGACAAAGTTAAATCAGGT This study 
SdrD-rev Sigma TAATATCTTCCGGATTCAATCCA This study 
amh100F Sigma AAAAGAGCTCTGAATTAGGAGTAATCTAATGCT This study 
amh203R Sigma ATCAGCATGCGATACATTTCATAAATTTTGAAATA This study 
PMg36e-Forw01 Sigma TATTCGGAGGAATTTTGAAATGGC This study 
SdrD-rev-2 Sigma TGCAGTATCATGTTTTGCAGTCG This study 
 
Primers were obtained freeze-dried and the stock solutions had a concentration of 100µM. 
The working solution was diluted to a concentration of 10µM. 
 
Table 2: Primer used and amplification length  
Primer Used for PCR and  
Sequencing 
 
Length Forward Reverse 
SdrD-A-F SdrD-A-R SdrD-lang 1540 bp 
SdrD-A-F SdrD-rev SdrD-700 765 bp 
SdrD-forw SdrD-A-R Sdrd-800 840 bp 
amh100F amh203R Full-length SdrD 3447 bp 
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S A-REGION (N1, N2, N3) B1 B2 B3 B4 B5 
 
                       1540bp 
    SdrD-A-F        SdrD-A-R 
 765bp 
SdrD-A-F  SdrD-rev 
   840bp 
 SdrD-forw  SdrD-A-R 
Figure 6:  Primers map. sdrD-A-F and sdrD-A-R used for sdrD-lang PCR, sdrD-A-F and 
sdrD-rev used for sdrD-700 PCR, sdrD-forw and sdrD-A-R used for sdrD-800 PCR 
Table 3: List of chemicals and reagents  
Chemicals Catalog number Manufacturer 
Reddy-mix-PCR master mix, 1x AB-0575/DC/LD Thermo scientific 
25mM MgCl2 R0971 Thermo Scientific 
TE-Buffer 1x pH:8  
(See Appendix 3 for composition)  




(See Appendix 3 for composition)  
Tris-base, T-5941    
EDTA, E-5134 
Sigma 
Seakem Le agarose 50004 Lonza Rockland ME  
Gel Red nucleic acid stain 41003-1 Biozium 
1 kb plus DNA ladder 10787-026 Invitrogen 
Big dye v.3.1 (Ready mix from sequence 
analyze lab) 
1304236 Life technology 
5X sequencing buffer (Ready mix from 
sequence analyze lab) 
1103132 Life technology 
ExoSap-It (10 U/µl) 78200 Affymetrix.USA 
Phusion DNA polymerase (2U/µl) 0181109 Biolabs 
dNTP(10mM) D7295 Sigma 
5X phusion GC buffer 0011309 Biolabs 
DreamTaqGreen PCR master mix (2X) 00156088 Thermo Scientific 
BSA 100x, working solution BSA (10X) 0181109 Biolabs 
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Buffer1.1 (1x) 0011306 Biolabs 
SacI (10 U/µl) 0501305 Biolabs 
SphI (10 U/µl) 0481304 Biolabs 
XbaI (10 U/µl) R7260 Sigma, Germany 
XhoI (10 U/µl) R0146s Sigma, Germany 
NEBuffer. 4 (1x) 0011309 Sigma, Germany 
SGM17-Gly medium  103K0183 Sigma, Germany 
Electrotransformation solution 57H0144 Sigma, Germany 
Washing Solution  Sigma, Germany 
M17 medium 103K0183 Oxoid, England 
Blood agar plate   
SGM17 agar plate SM17 + 
0.5%glucose 
Sigma, Germany 
SGM17 medium with 10µg/ml erythromycin See composition in Appendix 3 
SOC medium See composition in Appendix 3 
LB broth medium with 400µg/ml erythromycin See composition in Appendix 3 
Table 4: List of instruments and materials  
Instruments Name Manufacturer 
 
Centrifuge 
Biofuge Pico Heraeus 
Avanti J-26 XP Beckman Coulter, USA 
F-5430R Eppendorf AG, Germany 
Nanodrop spectrophotometer ND-100 Saveen Werner 
PCR machine T100 
GeneAmp 9700 
Bio-Rad, Singapore 
Applied biosystem, Singapore 
GFX PCR DNA and Gel 
Band Purification Kit 
28-9034-71 GE-healthcare, UK 
G:Box F3 Syngene Cambridge, UK 
Vortexer  119448347 Heidolph, Germany 
NucleoBond xtra midi column kit 11091008 MN, Germany 
NucleoBond xtra mini column kit 1112006 MN, Germany 
MicroPulser™ Electroporator 165-2100 Bio-Rad, USA 
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4. Methods 
 
DNA from a total of 51 S. aureus strains was isolated, and the A-region of sdrD was 
amplified by PCR, purified and the products were sequenced. The identity of the sequence 
was checked using Basic Local Alignment Search Tool (BLAST) program. All sdrD 
sequences were aligned using the program BioEdit version 7.2.5.  
 
Strain nr 32 was selected as representative for sdrD1 for insert preparation. Genomic DNA 
was isolated; full length PCR was performed, the PCR product checked on 1 % agarose gel, 
the product purified, restriction enzyme digestion was performed, and the product was 
visualized again on 1% agarose gel for restriction enzyme specification and used for ligation. 
Vector was isolated; restriction enzyme digestion was performed, the product was checked on 
1 % agarose gel, purified, and used for ligation. 
 
 
4.1 DNA Sequencing  
 
4.1.1 Rapid chromosomal DNA isolation by boiling 
	  
1. Bacteria were picked from a frozen pure culture by scratching the sterile loop across 
the surface of the culture.  
2. The loop was used to streak out the cells on the surface of a blood agar plate. 
3. The plate was incubated at 37 °C overnight. 
4. 8-10 bacteria colonies were dissolved in 200µl TE-buffer pH=8 in an eppendorf tube. 
5. The sample was centrifuged at 5000rpm for 5 minutes. 
6. The supernatant was discarded and the cell pellets were re-suspended in 100µl TE-
buffer 
7. pH = 8. 
8. Incubated for 10 minutes at 100 °C.   
9. The tubes were quickly chilled on ice and centrifuged at 5000 rpm for 5 minutes. 
10. The supernatant was transferred to another eppendorf tube and stored at -20 °C. 
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4.1.2 Polymerase chain reaction  
	  
Polymerase chain reaction (PCR) is a method used to make millions of identical copies 
(amplification) of a piece of DNA in vitro. Double-stranded DNA to be amplified is heated to 
about 94-98 °C for 30x cycles. DNA is denatured by high temperature to separate individual 
strands. The temperature is lowered to about 40-65 °C or 2-10 °C lower than the melting 
temperature for the primers, so that primers can react and stick to the short DNA pieces, 
which are complementary to the sequence of the strand to be amplified and not to each other. 
Then the temperature is raised to 72 °C and the polymerase replicates the DNA from 3’ -OH 
end of the primers. Then two new DNA strands are gained from one starting DNA strand. The 
entire new DNA created acts as template for new DNA, so that the increase will be 
exponential. (Sambrook et al., 1989) 
Gradient PCR includes the use of gradually decreasing annealing temperature in cycling 
reaction to find the optimal annealing temperature for primer pair combination(Padmakumar 
and Varadarajan, 2003). 
 
Preparation of sample for PCR  
 
1. Concentrations in the final working PCR mixture were 0.5x Reddy-mix, 0.5µM 
forward and revers primers (see Table 2 for primer list) and 5µl or 3µl templates. The 
volume was adjusted to 25µl by double distilled water.  
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Table 5: Cycling program used to amplify DNA from S. aureus sdrD A-region for strain nr.1 
to nr.51 
SdrD-700 and SdrD-800 
Procedure Temperature Duration 
Initial denaturation 94 ˚C 2 min 
Repeat cycling 30X 
Final denaturation 94 ˚C 30 sec 
Annealing 60.4 ˚C 30 sec 
Initial elongation 72 ˚C 50 sec 
Final elongation 72 ˚C 3 min 
Cooling 4 ˚C ∞ 
 
 
Optimization of PCR 
 
An optimized PCR amplification will produce a single, bright band on gel. To get a single, 
bright band on a gel one has to optimize the enzyme concentration, magnesium concentration, 
denaturation temperature and time, the annealing temperature and time, and cycles. Very high 
enzyme concentration and too many cycles may give nonspecific background products. 
Incomplete denaturation, very low enzyme concentration and low cycles reduce desired 
product yield. While very high or long denaturation leads to loss of enzyme activity. The 
magnesium concentration may affect primer annealing, strand dissociation temperature of 
both template and PCR product and specificity. (White, 1990) 
 
4.1.3 Determination of DNA concentration 
	  
Due to the aromatic bases within its structure, DNA absorbs UV light at 260 nm. Purines 
(thymine, cytosine and uracil) and pyrimidines (adenine and guanine) both have peak 
absorbance at 260 nm, thus making NanoDrop spectrophotometer suitable for quantifying 
DNA samples. NanoDrop spectrophotometers can also be used to quantify proteins using 
direct absorbance. (Desjardins and Conklin, 2010)  
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Proteins and phenolic compounds have strong absorbance at 280nm, because of aromatic 
amino acid side chains (tryptophan, phenylalanine, tyrosine and histidine) within proteins. 
Similarly, the aromatic of phenol groups of organic compounds absorbs strongly near 280 nm. 
(Desjardins and Conklin, 2010) 
Pure nucleic acids yield 260/280 ratio of around 1.8 for DNA, and a 260/280 ratio of around 
2.0 for RNA. Acidic blank solutions sample will under-represent the ratio by 0.2-0.3, while a 
basic blank solution sample will over-represent the ratio by 0.2-0.3. Significantly different 
purity ratio may indicate the presence of protein, phenol or other contaminants that absorb 
strongly at or near 280 nm. (Desjardins and Conklin, 2010) 
 
Procedure 
1. The upper and lower optical surfaces of the NanoDrop spectrophotometer sample 
retention system were cleaned by pipetting 5µl of clean deionized water on to the 
lower optical surface. 
2. The lever arm was closed to ensure that the upper pedestal comes in contact with the 
deionized water, and both optical surfaces were wiped off with a clean, dry, lint-free 
lab wipe. 
3. The NanoDrop software was opened and the Nucleic Acid application was selected.  
Dispensing 1.5µl of deionized water onto the lower optical surface performed a blank 
measurement. 
4. Once the blank measurement was completed, both optical surfaces were cleaned with 
a clean, dry, lint-free lab wipe. 
5. Dispensed 1.0µl of DNA sample onto the lower optical pedestal and closed the lever 
arm.  
6. Selected “Measure” in the application software. And the software automatically 
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4.1.4 Gel electrophoresis 
	  
Gel electrophoresis is a method for separating and identifying proteins or fragments of DNA 
or RNA in a gel made of agarose or polyacrylamide between thin glass plates. The method 
can detect bands that contain 1-10ng DNA. Agarose gels have lower resolving, but greater 
range of separation than polyacrylamide. The two ends of the gel in contact with each 
electrode buffer. Negatively charged molecules at the appropriate pH will migrate towards the 
anode (positive pole). The walking speed depends on the size of the molecules to be 
separated, voltage across the gel, pore size and concentration of the gel material. One often 
uses a dye bromphenolblue to see how far the electrophoresis has reached. (Sambrook et al., 
1989) 
 
Preparation of 1% agarose Gel 
1. 1 g Seakem® agarose was weighed and mixed in 100 ml TAE-buffer solution to make 
1% gel. 
2. The mixture was heated to boil temperature in a microwave oven, until when the 
solution was dissolved and clear 
3. The agarose was allowed to cool slightly, mixed with 5µl gelred and poured into the 
casting tray.  
4. Thereafter the agarose gel was left to solidify for 25 minutes. 
  
Agarose gel electrophorese 
1. The gel in its casting tray was placed in a buffer chamber connected to a power 
supply. 
2.  Running buffer (TAE 1x) was poured into the chamber until the gel was completely 
covered.  
3. The comb was withdrawn to form the wells into which PCR sample will be loaded. 
4. When all wells have been loaded with sample, the power supply switched on with 
100V, 200mA.  
5. Electrophoresis for 1 hour and 15 minutes, the gel was then moved and photographed 
using G: BoxF3. 
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4.1.5 Purification of PCR-Product 
	  
Before starting the sequencing reaction, it is important to remove excess dNTP, DNA 
polymerase, and primer dimer from the PCR-products. ExoSapIt was used to purify the PCR- 
product. ExoSapIt contain two hydrolytic enzymes, Exonuclease I and shrimp alkaline 
Phosphatase. Exonuclease I degrades residual single stranded primers and single strand DNA. 
Shrimp alkaline phosphatase hydrolyzes the remaining unwanted dNTPs, which interferes 
with sequencing from the PCR mixture. (Hanke and Wink, 1994, Dugan et al., 2002, Kim and 
Blackshaw, 2001) 
 
Purification of PCR- product using ExoSapIt 
 
1. 0.7U Exo-SAPIt was added to each 15µl of PCR-product and the tubes were placed in the 
PCR thermo cycler. 
2. The Cycling-program was adjusted (Table 6). 




Table 6: Cycling program for ExosapIt 
Procedure Temperature Duration  
Degrades & 
Hydrolyzes 
37 °C 1 min 
37 °C 60 min 
Inactivate ExoSapIt 85 °C 15 min 
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4.1.6 Sequencing of DNA 
	  
DNA sequencing is the method used to characterize and confirm order of nucleotide in DNA. 
The method used to characterize the identity of newly cloned DNA, confirm the identity of a 
clone and PCR products. It is also used to identify polymorphism. (Sambrook et al., 1989, 
Hanke and Wink, 1994) 
The enzymatic method developed by Frederick Sanger and coworkers in 1977. Because of its 
comparative ease, the Sanger method was soon automated and was the method used in the 
first generation of DNA sequencing. The methods can directly sequence only relatively short 
300-1000 nucleotide long DNA fragments in a single reaction. (Sambrook et al., 1989) 
In this study, A 3130 Genetic Analyzer (ABI/Life Technologies) and BigDye Terminator 
v.3.1 cycle-sequence reaction reagent was used to perform direct sequencing. DNA sequence 
was analyzed by capillary electrophoresis automatically and the result was presented as an 
electro-photogram.  
Preparation of sample for sequencing 
1. PCR-products purified with ExoSap- It 
2. The final concentration in the PCR mixture was 0.75x sequencing buffer, 0.5µM 
primer forward or revers (see Table 2 primer list), 3.0µl template (purified by 
EXoSapIt), 1.0µl v.3.1Bigdye and 12.0µl ddH2O. 
3. The PCR mixture mixed well and PCR was run at program in Table 7. 
4. The samples were delivered to the sequencing laboratory to analyze by capillary 
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Table 7: Sequencing cycling program 
PCR program 
Procedure Temperature Duration 
Initial denaturation 96 ˚C 1 min 
Repeat cycling 30 × 
Final denaturation 96 ˚C 10 sec 
Annealing 50 ˚C 5 sec 
Initial elongation 60 ˚C 4 min 
Final elongation 4 ˚C 15 min 






BLAST is a program for aligning query sequences against those present in a selected target 
database. The program is provided by National Center for Biotechnology Information (NCBI) 
and access point for this tool is http://blast.ncbi.nlm.nih.gov/Blast.cgi. (Johnson et al., 2008) 
 
BioEdit is a biological sequence alignment editor program. The program is used to 
manipulate and analyses of sequences. The program offer the tools required to create and 
manipulate restriction enzyme mapping, annotatable plasmid drawing, and several built in 
analysis options. (Hall, 1999) 
 
The phylogenetic tree was obtained from http://www.phylogeny.fr. This is free online data 
program that can used to estimate the evolution of a genetically related group of organisms 
and identification of homologous sequences. The program can analyze both DNA sequence 
and amino acids sequence. (Dereeper et al., 2008)  
 
One click mode is used to create the phylogenetic tree (see figure 19 & 20). One click mode is 
designed for biologist with no experience in bioinformatics to create phylogenetic tree. The 
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set of DNA sequence or amino acid sequence submitted (copy, paste) in FASTA format and 





Cloning involves several basic molecular biology techniques, such as PCR, DNA agarose gel 
electrophoresis, enzymatic reaction, ligation and bacterial transformation. Cloning is using 
nuclear DNA from one organism to create a second organism with the same nuclear DNA. 
Sub-cloning is cutting a piece of DNA from one organism and inserting it into a plasmid 
where it can be replicated by a host organism. (Griffiths et al., 1999) 
There are two major DNA components; a plasmid and an insert that are to be joined into a 
single DNA molecule. The key steps in sub-cloning are preparing insert DNA, Preparing 
plasmid, cutting insert and plasmid with the same enzyme at precise location, joining two 
DNA fragments covalently, transformation to a host cell, selecting host cells that containing 
recombinant DNA. (Griffiths et al., 1999) 
 Insert and plasmid are generated by digestion with appropriate restriction enzymes, and the 
complementary ends of the plasmid and insert are then joined by DNA ligase (Griffiths et al., 
1999). 
 
4.3.1 Preparation of full length sdrD Insert   
	  
One S. aureus strain (strain nr. 32) was selected as representative for SdrD1. By using lysis 
method genomic DNA was isolated from S. aureus.  Full-length sdrD was amplified by PCR 
(Table 8). PCR product was checked on 1% agarose gel and purified by using GFX PCR 
DNA and Gel band purification kit. Purified DNA was cut by restriction enzyme.  
Isolation of genomic DNA from S. aureus by lysis method 
1. Bacteria were picked from a frozen pure culture by scratching the sterile loop across 
the surface of the culture.  
2. The loop was used to streak out the cells on the surface of a blood agar plate. 
3. The plate was incubated at 37 °C overnight. 
4. A small loop of bacteria from overnight plate re-suspend in 100µl lysismix and 
incubated for 30 min at 37 °C 
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5. The sample was spun down at 4500 rpm for 5min; the supernatant was transferred in a 
new tube and placed at 100 °C for 5 min. 
6. 200µl TE-buffer pH-8 (1X) was added and stored at -20 °C 
 
Preparation of master mix for PCR 
 
1. Master mix was prepared for each 20µl reaction by mixing, 1x Phusion GC buffer, 
0.5µM forward and reverse primers (See Table 2 for primer list), 0.2mM dNTP, 0.02U 
Phusion DNA polymerase, 1.5µl template and the final volume adjusted by adding 
double distilled water. 
2. PCR was run as explained in table 8. 
 
 
Table 8: Full length SdrD amplifying PCR cycling Program 
PCR Program 
Procedure Temperature Duration 
Initial denaturation 98 °C 30 sec 
Repeat cycling 30x 
Final denaturation 98 °C 10 sec 
Annealing 61.1 °C 15 sec 
Initial elongation 72 °C 3 min 
Final elongation 72 °C 10 min 
Cooling 4 °C ∞ 
 
 
Extraction and purification of DNA from agarose gel 
 
GFX PCR DNA and Gel band purification kit was used to purify full-length S. aureus sdrD 
PCR-product from Gel band. GFX MicroSpin column involves four main steps, capturing of 
DNA, binding, washing and drying, and eluating. In capture step, protein will be denatured 
and agarose gel dissolved, then binding buffer promotes the binding of DNA to a glass fiber 
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matrix. Washing buffer washed away proteins and salt contamination. At the last step purified 




1.  1.5 ml micro centrifuge DNase-free tube was weighed and the weight was recorded.  
Using a clean scalpel, the agarose band containing the sample of interest was cut out. 
The agarose gel band was placed in a pre-weighted DNase-free 1.5 ml micro 
centrifuge tube. The weight of the micro centrifuge tube containing the agarose band 
was recorded and the weight of the agarose slice was calculated.  
2. 10µl capture buffer type 3 was added to for each 10 mg of gel slice. The mixture was 
incubated at 60 °C for 20 minutes until the agarose was completely dissolved. The 
mixture was inverted every 3 minutes. 
3. If the color of solution was yellow, there was no need to adjust pH. If not see the 
protocol to adjust the pH. 
4. The sample mix was loaded onto the assembled GFX MicroSpin column and 
collection tube, and spun at 13000 rpm for 30 seconds. 
5. The flow was discarded and the GFX MicroSpin column was placed back inside the 
collection tube. 
6. From wash buffer type-1, 500µl was added to GFX MicroSpin column, and spun at 
13000 rpm for 30 seconds. 
7. The flow was discarded and the GFX MicroSpin column was transferred to a new 
micro centrifuge collection tube. 
8. 25µl Elution buffer type 4 was added to the center of the membrane in the assembled 
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Restriction enzyme digestion for full-length sdrD insert 
 
1. Master mix was prepared by mixing 9.2ng template (purified), 0.1x Buffer1.1, 1x 
BSA, 0.2U SacI and SphI, and 13µl ddH2O. 
2. The sample was incubated at 37 °C for 4 hour. 
3. The product was checked on 1 % agarose gel for restriction enzyme specification. 
 
4.3.2 Preparation of plasmid 
	  
Two different pMG36e plasmids were used; Alternative one pMG36e plasmid containing 
sdrD from S. aureus strain NCTC8325 ( pMG36e:SdrD_NCTC8325) and  alternative 2 
“empty” pMG36e without sdrD. Both plasmids were isolated by the same procedure from L. 
lactis.  
 
Plasmid isolation using NucleoBond xtra midi/mini column kit   
 
Plasmids are small, circular, extra-chromosomal DNA molecules found in bacteria cells. 
Plasmids carry genes for antibiotic resistance and replicate independently of the bacteria 
genome. (Griffiths et al., 1999) 
The basic principles are lysis of bacterial cells by an optimized set of formulated buffers 
based on Sodium hydroxide (NaOH) or Sodium dodecyl sulfate (SDS) (Birnboim and Doly, 
1979).  
When the bacterial cell pellet are treat with buffer RES and lysed by LYS buffer, proteins, 
chromosomal and plasmid DNA are denatured and RNA is degraded. Then neutralization 
buffer NEU precipitate SDS by pulling down proteins. Chromosomal DNA, and plasmid 
DNA can revert to its native structure and remains in solution. Then equilibration buffer EQU 
and washing buffer WASH is used to remove all traces of contaminants. Elution is carried out 
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Procedure 
1. L. lactis colony with PMG36e plasmid (both type plasmid) was cultivated in 100 ml 
SGM17 media with 10µg/ml erythromycin and was incubated at 32 °C overnight 
without shaking. 
2. After overnight incubation the whole contents of flask was transferred to a plastic 
bottle with lid.  
3. The sample was centrifuged at 6000 rpm for 20 minutes. 
4. The supernatant was discarded and the pellet was re-suspended in 4ml PBS buffer, 
which contained 1mg/ml lysozyme (5µl of 200 mg/ml). 
5. The sample was incubated at 37 °C for 2 hours in water bath. 
6. 4ml RES buffer was added to the sample and mixed well. 
7. 4ml Lysis buffer was added and shaken gently. Thereafter incubated for 5 minutes in 
room temperature. 
8. NucleoBond xtra midi column kit was prepared as mentioned in protocol by washing 
with 12 ml EQU buffer. 
9. After 5 minutes of incubation 8ml NEU buffer was added to the sample and shaken 
slowly to mix. 
10.  The whole content of the sample was transferred to the Column and 5ml EQU buffer 
was added to the column. 
11. The filter of column was removed and 8ml WASH buffer was added directly to the 
sample. 
12. 5 ml ELU buffer was added to the column. 
13. The column was removed and 4 ml Isoprpanol was added to the sample. 
14. The sample was centrifuged at 15000 rpm for 30 minutes. 
15. The supernatant was discarded and 2 ml 70% ethanol was added to the pellet. (NB! 
Difficult to see the pellet) 
16. The sample was centrifuged at 15000 rpm for 10 minutes and the supernatant 
discarded. 
17. The pellet was dried for 1 hour in room temperature. 
18. The pellet was dissolved in 200µl TE (1X) buffer and was transferred to Eppendorf 
tube. 
19. The concentration was determined by nano-drop spectrometry and the sample was 
stored at -20 °C. 
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Isolation of plasmid from E. coli using NucleoBond xtra midi column kit 
1. Colonies was inoculated in 100 ml LB medium with erythromycin 400µg/ml and 
incubated at 37 °C overnight while shaking at 225rpm.  
2. After overnight incubation the whole contents of flask was transferred to a plastic 
bottle with lid  
3. The sample was centrifuged at 6000 rpm for 20 minutes. 
4. 8ml RES buffer was added to the sample and mixed well. 
5. 8ml Lysis buffer was added and shaken gently and incubated for 5 minutes in room 
temperature. 
6. NucleoBond xtra midi column kit was prepared as mentioned in protocol by washing 
with 12 ml EQU buffer. 
7. After 5 minutes incubation 8ml NEU buffer was added to the sample and shaken 
slowly to mix. 
8.  The whole content of the sample was transferred to the Column and 5ml EQU buffer 
was added. 
9. The filter of column was removed and 8ml WASH buffer was added directly to the 
sample. 
10. 5ml ELU buffer was added to the column.  
11. The column was removed and 4 ml Isoprpanol was added to the sample. 
12. The sample was centrifuged at 15000 rpm for 30 minutes. 
13. The supernatant was discarded and 2 ml of 70% ethanol was added to the pellet. (NB! 
Difficult to see the pellet) 
14. The sample was centrifuged at 15000 rpm for 10 minutes and the supernatant was 
discarded. 
15. The pellet was dried for 1 hour in room temperature. 
16. After 1 hour the pellet was dissolved in 200µl TE (1X) buffer and transferred to an 
eppendorf tube. 
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Restriction enzyme digest for plasmid pMG36e:SdrDNCTC8325 
 
1. 16.1ng template, 0.1x Buffer 4, 1x BSA, 0.2 U XbaI and XhoI and 33µl ddH2O, were 
mixed to prepare the sample. 
2. The sample was incubated at 37 °C for 4 hour. 
3. The product was checked on 1% agarose gel.  
 
 
Restriction enzyme digest for plasmid pMG36e from L. lactis or E. coli 
 
1. 18.7ng template, 0.1x Buffer1.1, 1x BSA, 0.2U SacI, and SphI and 33µl ddH2O, were 
mixed to prepare the sample. 
2. The sample was incubated at 37 °C for 4 hour. 





Ligation is the process of joining two pieces of DNA from different sources together with the 
formation of covalent bonds. DNA ligase is the enzyme used to catalyze ligation reaction and 
requires ATP. (Pascal, 2008) 
T4 DNA ligase catalyzes both blunt end and cohesive end ligation. To prevent both type of 
ligation, it needs to adjust ATP concentration. Increasing ATP concentration to 5mM gives 
inhibition of the blunted end ligation, and further increasing of ATP concentration to 7.5mM 
inhibited both ligations. (Ferretti and Sgaramella, 1981) 
 
 
Preparation of ligation mix 
1. Master mix was prepared with three different vector:insert ratio (Table 9) 
2. The sample was incubated at 16 °C overnight. 
3. After overnight incubation, the sample transformed into E. coli.  
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Table 9: Ligation mix with three different pMG36e(plasmid): strain nr.32(insert) ratio 
Ligation mix per tube 
1:1 1:3 1:10 
16µl   ddH2O 13µl   ddH2O 6µl   ddH2O 
2µl T4 buffer 2µl T4 buffer 2µl T4 buffer 
0.5µl pMG36e  1µl pMG36e  1µl pMG36e  
0.5µl Strain nr.32  3µl Strain nr.32 10µl Strain nr.32  
1µl T4 Ligase 1µl T4 Ligase 1µl T4 Ligase 
 
Transformation of plasmid DNA (pMG36e) into E. coli  
1. The competent E. coli (DH5) bacteria cells and isolated plasmid DNA 
(PMG36e) was melted on ice.  
2. 200µl competent bacteria cells were added to each ice-cold falcon tube. 
3. 2µl plasmid DNA (from overnight incubated ligation mix) was added to one 
of cold falcon tube.    
4. Incubated on ice for 30 minutes. 
5. The cells were heat shocked at 42 °C (water bath) for 90 seconds. 
6. The sample was placed on ice for 90 seconds. 
7. 800 µl S.O.C added to each Falcon tube. 
8. Incubated at 37 °C while shaking at 225 rpm for 45 minutes. 
9. 200 µl of the solution plated out on LA+-plates with erythromycin 400µg/ml.  
10. Incubated at 37 °C overnight. 
 
 
4.3.4 Colony screening and selection of transformants  
 
1. 10.5µl ddH2O, 1x DreamTaq Green, 0.4µM forward and revers primers (see Table 2 
primer list) and 1 colony (from incubated plate one colony was picked with a sterile 
toothpick) were mixed to prepare the sample. 
2. The same toothpick was used to streak on new LA+-plates with erythromycin 
400µg/ml for further use and incubated at 37 °C overnight. 
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3. Cycling program was adjusted (Table 10). 
4. PCR-products were checked on 1% agarose gel. 
 
Table 10: Insert screening PCR 
Cycling Program 
Procedure Temperature Duration 
Initial denaturation 94 °C 5 min 
Repeat cycling 35x 
Final denaturation 94 °C 30 sec 
Annealing 55 °C 10 sec 
Initial elongation 72 °C 2 min 
Final elongation 72 °C 7 min 




Plasmid isolation from E. coli using NucleoBond xtra mini column kit 
1. Colonies that contained the right insert was inoculated in 5 ml LB medium with 
erythromycin 400µg/ml and incubated at 37 °C overnight while shaking at 225rpm.  
2. The sample was centrifuged at 11000 x g for 30 seconds at room temperature and 
supernatant was discarded. 
3. 250µl buffer A1 was added to the sample and the pellet was re-suspended by pipetting 
up and down. 
4. 250µl buffer A2 was added to the sample and incubated for 5 minutes after mixing by 
inverting the tube. 
5. 300µl buffer A3 was added to the sample and mixed by inverting the tube. 
6. The sample was centrifuged at 11000 x g for 10 minutes at room temperature. 
7. The supernatant was transferred to Nucleospin plasmid column (max. of 750µl) and 
centrifuged for 1 minute at 11000 x g. This step was repeated to load the remaining 
sample. 
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8. Preheated (to 50 °C), 500µl buffer AW was added to the sample and centrifuged for 1 
minute at 11000 x g.  
9. The supernatant was discarded and centrifuged for 2 minutes at 11000 x g and the 
collection tube was discarded. 
10. The column was placed on a new collection tube and 50µl buffer AE added. 
11. The sample was incubated for 1 minute at room temperature and was centrifuged for 1 




4.3.5 Identification of E. coli transformants containing pMG36e:SdrD1 
1. To identify the right constructs (pMG36e:SdrD1) sequencing was done. 
2. 12µl ddH2O, 0.75x sequencing buffer, 0.5µM PMG36e-Forw01 or 0.5µM SdrD-rev-
02 (see Table 2 primer list), 1.0µl of V.3.1 Bigdye and 6ng template was mixed to 
prepare the sample.  





4.4.1 Competent cells 
	  
Competent cells are cells that are exposed to change the state of the cell wall; this implies 
change in permeability of the cell membrane, to get the ability of a cell to take up 
extracellular DNA. Competence of cells occurs under natural, chemical and electronic 
condition. Natural competence occurs when bacteria express specialized proteins that allow 
the cell to bind and take up large pieces of DNA from environment. This could be 
advantageous due to its role in horizontal gene transformation.  Under chemical competence, 
the cells are incubated in a solution under cold condition and exposed to heat shock, while 
electro competence cells are briefly shocked with an electric field. (Mercenier and Chassy, 
1988) 
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Procedure  
1. 100µl L. lactis strain M1363 cells was plated out on the surface of SGM17-Gly 
plate and incubated over night at 30 °C. 
2. 5ml of SGM17-Gly was inoculated with the overnight colonies and incubated 
overnight at 30 °C 
3. 100ml of SGM17-Gly was inoculated with 100µl of the overnight culture, the cells 
were grown at 30 ˚C to an OD600 of 0.5 - 0.8 
4. The culture was transferred into two pre-chilled 50 ml falcon tubes.  
5. The sample was centrifuged at 4500 rpm for 15 min at 4 °C and the supernatant 
were discarded. 
6. The pellet was re-suspended with 50 ml ice-cold washing solution by pipetting up 
and down, and vortex for 1 minute 
7. The sample was spun down at 4500 rpm at 4 °C for 15 min, the supernatant was 
discarded, the tubes were inversed to remove all traces of washing solution 
8. The sample was washed again with 50ml washing solution, spun down at 4500 
rpm at 4 °C for 15 minutes, supernatant was discarded and the tubes were inversed 
to remove all traces of washing solution 
9. The pellets were re-suspended again with 10 ml of ice-cold washing solution and 
the sample was transferred in a new 50 ml tube, the same procedure was repeated 
2 times. 
10. The sample was spun down at 4500 rpm for 15 min at 4 °C, supernatant was 
discarded, tubes were inversed to remove all traces of washing solution 
11. The pellet was re-Suspended in 1 ml ES solution, aliquot 100 µl in sterile 1.5 ml 
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4.4.2 Electro-transformation  
	  
Electro-transformation also known as electroporation is the most efficient tool for plasmid 
DNA uptake.  It involves the application of high-voltage electric field pulses of short duration 
to induce the formation of transient pores in the membranes of cells. (McIntyre and 
Harlander, 1989) 
 
Electro-transformation efficiency is depending on number of cell washes to electroporation, 
cell number, DNA amount and cell growth phase. For high degree of success cell of high 
resistance and very low conductivity is required. The basic protocol involves preparation of 
cells, which usually are harvested in mid-log phase, following a series of washing steps, and 
applied electric field pulse. After application of the pulse, the cells are diluted in ice-cold 
medium and plated on the appropriate selective medium. (Gasson and vos, 1994) 
 
  Electro-transformation of Constructs (pMG36e:sdrD1) from E. coli into L. lactis 
 
1. A tube (100µl) of electro-competent L. lactis strain M1363 cells and purified 
pMG36e:sdrD1 DNA from E. coli was melted on ice. 
2. 2µl of plasmid DNA was added to 100µl of electro-competent L. lactis strain M1363 
cells on ice and incubated for 5 minutes 
3. The sample was transferred to a 0.2 cm electro-poration cuvette 
4. The sample was electroporated with 2,5 kV/25µF/400 Ω 
5. 900µl of SMG17-Gly was added immediately and homogenized by pipetting up and 
down 
6. The cells suspension was transferred to a sterile 1.5ml tube and incubated for 3 hours 
in a water bath at 30 °C 
7. 100µl the cells suspension was plated out on SMG17 with 10µg/ml erythromycin agar 
plate and incubated at 30°C for 48 hours  
8. The colonies were spread out to a new SMG17-ery 10µg/ml agar plate for further use. 
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Plasmid isolation from L. lactis NucleoBond using xtra mini column kit 
 
1. A small loop of bacteria colonies was re-suspended in 5ml SMG17-ery 10µg/ml media 
and incubated overnight at 30 °C 
2. The sample was centrifuged at 4500 rpm for 15 minutes 
3. The pellet was re-suspended in 125µl PBS buffer containing 1mg/ml lysozyme and 
incubated for 2 hours on a water bath at 37 °C 
4. 250µl A1 buffer was added to the sample and mixed well by inverting the tube. 
5. 250µl A2 buffer was added and mixed gently and incubated for 5 minutes in room 
temperature. 
6. 300µl A3 buffer was added to the sample and mixed well by inverting the tube. 
7. The sample was centrifuged for 10 minute at 11000xg at room temperature. 
8. The supernatant was transferred to the Nucleospin plasmid Column and centrifuged 
for 1 minute at 11000x g and supernatant was discarded. 
9. 500µl AW buffer was heated at 50 °C and added directly to the sample, thereafter 
centrifuged for 1 minute at 11000xg and supernatant was discarded. 
10. 600µl A4 buffer was added to the column, centrifuged for 1 minute at 11000xg and 
supernatant was discarded. 
11.  Centrifuged again for 2 minutes at 11000xg and the collection tube was discarded. 
12. The column was transferred to a new tube; 50µl AE buffer was added, incubated for 1 
minute at room temperature and centrifuged for 1 minute at 11000xg. 
The transformants were checked for the presence of construct (pMG36e:sdrD1) by insert 
screening (see 4.3.4 for procedure). Insert screening sample mix was modified; 2.0µl plasmid 
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5. Results 
 
5.1 Isolation of DNA from S. aureus  
To evaluate allelic variation among sdrD from S. aureus isolates, it was needed to isolate 
DNA before doing PCR and sequencing. DNA from S. aureus strains MSSA476 and 
NCTC8325 were isolated. The purity and concentration of the DNA isolated from strain 
MSSA476 and NCTC8325 was measured by Nanodrop spectrometry. The absorbance was 
read at 260nm.  
The results showed that the purity of nucleic acids yield (260/280 ratio) was 1.88 for strain 
MSSA476 with concentration 99.46 ng/µl. 1.79 for strain NCTC8325 with concentration 
24.46 ng/µl. The purity 1.88 and 1.79 were suggested that the DNA should be pure enough to 
proceed. The DNA purity and concentration of the 51 S. aureus strains was not determined. 
 
5.2 Optimization of sdrD A-region PCR 
SdrD-lang PCR  
For detecting the full-length A-region of sdrD (SdrD-lang, 1540 bp), the PCR program was 
needed to optimize. Two bacterial strains S. aureus strain MSSA476 and S. aureus strain 
NCTC 8325 were used for optimization. Isolation of DNA for both strains was performed as 
described under “method”, and purity of DNA was measured with NanoDrop 
spectrophotometer.  
SdrD-lang PCR was run using the program given in Table 11. As the Figure 7 shows, SdrD-
lang S. aureus strain NCTC8325, lane ”B” gave one single bright band at size approximately 
1540 bp, but SdrD-lang S. aureus strain MSSA476 lane “A” gave single band at size around 
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Table 11: sdrD-lang cycling program 
sdrD-Lang 
Procedure Temperature Duration 
Initial denaturation 95°C 5 min 
Repeat cycle 30× 
Denaturation 95°C 30 sec 
Annealing  62°C 30 sec 
Initial elongation 72°C 160 sec 
Final elongation  72°C 4 min 
Cooling sample 4°C ∞ 
 
 
Figure 7: sdrD-lang on 1% agarose gel; molecular weight standard (1kb plus), lane A S. 
aureus strain MSSA476, and lane B S. aureus strain NCTC8325.  
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Optimization of sdrD-lang PCR  
 
 Since the result of SdrD-lang PCR for S. aureus strain MSSA476 gave additional multiple 
weak bands, the optimization of PCR was necessary. 
This was done by optimized elongation time (initial elongation time in Table 11, 160 sec 
changed to 140 sec), and the result showed one single bright band at approximately 1540 bp 
for sdrD-lang S. aureus strain MSSA476 as expected (Figure 8).   
The sdrD-lang PCR for both S. aureus strains (MSSA476 and NCTC8325) was optimized 
(Figure 8), but the size was not suitable for sequence analysis at the sequencing unit at the 
department. Because of the limitation of the read length of the DNA sequencer (the read 
length is only up to 1000bp sequences), the sdrD A-region sequence was divided into two 
parts, 765bp (SdrD-700) and 840bp (SdrD-800). 
 
Figure 8: An image of SdrD-lang on 1 % agarose gel; molecular weight standard (1Kb plus), 
lane A MSSA476-lang, lane B NCTC8325-lang and lane N negative control 
 
SdrD-700 and sdrD-800 
The initial PCR was performed using the cycling program given in Table 12.  The result from 
sdrD-700 and sdrD-800 showed a fragment of 850 bp in addition to several weak multiple 
bands for both S. aureus strains (strain MSSA476 and strain NCTC8325) (see Figure 9). A 
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single bright band was expected at a size 765 bp for sdrD-700 and 840 bp for sdrD-800. 
Therefore optimization continued by changing MgCl2 concentration.  
 
 
Table 12 Cycling program for sdrD-700 and sdrD-800 for strains MSSA476 AND 
NCTC8325 
sdrD-700 and sdrD-800 
Procedure Temperature Duration 
Initial denaturation 94 ˚C 2 min 
Repeat cycling 30× 
Final denaturation 94 ˚C 30 sec 
Annealing 60 ˚C 30 sec 
Initial elongation 72 ˚C 50 sec 
Final elongation 72 ˚C 2 min 
Cooling 4 ˚C ∞ 
 
 
Figure 9: 1% agarose gel. Molecular weight standard (1Kb plus), lane A PCR product from 
strain MSSA476 sdrD-700 (left) and sdrD-800 (right), lane “B” PCR product from strain 
NCTC8325 sdrD-700 (left) and sdrD-800 (right). 
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Optimization by changing MgCl2 concentration for sdrD-700 and sdrD-800 PCR 
 
The PCR was run using the cycling program shown in Table 12.Three different MgCl2 
concentrations were tested, 2.5mM, 2.0mM and 1.5MgCl2.  
The sdrD-700 PCR with MgCl2 concentration of 2.5mM resulted in one single bright band at 
a size 850bp, but produced additional weak multiple bands with 2.0mM and 1.5mM for strain 
MSSA476. (Figure 10) 
The sdrD-800 PCR with MgCl2 concentration of 1.5mM resulted one single bright band at a 
size 850bp, but produced additional weak multiple bands with 2.5mM and 2.0mM for strain 
MSSA476 (see Figure 10). 
The sdrD-700 PCR with all MgCl2 concentration resulted one single band and extra weak 
multiple bands at 850bp for strain NCTC8325. (Figure 10)  
The sdrD-800 PCR with MgCl2 concentration of 2.5mM and 1.5mM resulted one single 
bright band at a size 850bp, but 2.0mM produced extra weak multiple bands in addition to 
single band for strain NCTC8325 (see Figure 10). 
 
Figure 10: An image of 1% agarose gel and PCR cycling program that illustrate an 
optimization of PCR by different concentration of MgCl2. molecular weight standard (1Kb 
plus), sample in lane A, contain 2.5mM MgCl2, lane B, Contain 2.0mM MgCl2, lane C 
1.5mM MgCl2. 
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Optimization of annealing temperature by gradient PCR 
 
Since the results were yet inconclusive, gradient PCR was used to optimize the annealing 
temperature (See Table 13) so as to get one bright single band for both (SdrD-700 and SdrD-
800).  
From a total of 1.5mMol MgCl2 concentration obtained one bright single band at 850 bp at 
60.4 °C (lane C) for SdrD-700 and SdrD-800 PCR for S. aureus strain NCTC8325 (see Figure 
11).  
For S. aureus strain MSSA476 one bright single band at 850 bp was achieved at 62.0 °C (lane 
B) for SdrD-700 PCR (see Figure 12). 
For SdrD-800 PCR one weak single bright band at a size 850 bp observed at 63.0 °C (lane A), 
62.0 °C (lane B) and at 50.0 °C (lane H) (see Figure 12).  
PCR product from annealing temperature that gave single bright band was sequenced. PCR 
product from strain NCTC8325 gave a good sequence result, but from strain MSSA476 no 
sequence result was obtained.   
Since there was an unexpected single band at 50.0 °C (lane H, figure 12) and no sequence 
result were obtained from the strain MSSA476 DNA, S. aureus strain NCTC8325 was chosen 
for further use as positive control.  
The final PCR program that used to amplify S. aureus strain 1-51 is shown in Table 5. 
Table 13: Cycling program sdrD-700 and sdrD-800 for strains MSSA476 AND NCTC8325 
sdrD-700 and sdrD-800 PCR 
Procedure Temperature Duration 
Initial denaturation 94 ˚C 2 min 
Repeat cycling 30x 
Final denaturation 94 ˚C 30 sec 
Annealing  63-50 ˚C 30sec 
Initial elongation 72 ˚C 50sec 
Final elongation 72 ˚C 2 min 
Cooling 4 ˚C ∞ 
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Figure 11: An image of 1% agarose gel showing the result of optimization by annealing 
temperature S. aureus strain NCTC8325, molecular weight standard (1Kb plus), highest 
temperature in lane A (63 °C) and lowest temperature in lane H (50 °C). The green circle 
around lane C shows the best results. 
 
 
Figure 12: An image of 1% agarose gel showing the result of optimization by annealing 
temperature S. aureus strain MSSA476, molecular weight standard (1Kb plus), highest 
temperature in lane A (63 °C) and lowest temperature in lane H (50 °C). The red circle around 
lane H shows an expected band. 
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5.3 SdrD-700 and SdrD-800 PCR for S. aureus strains nr.1 to 51 
 
PCR program for strain NCTC8325 was optimized as indicated in Table 5. This program was 
used to run sdrD-700 and sdrD-800 PCR on 51 S. aureus strains that isolated from healthy 
carriers in Tromsø 6 study. 
 
SdrD-700 PCR product 
 
As it is shown in Figure 13, for strain nr.1 to 20, one single bright band at a size 850 bp was 
obtained only from DNA strain nr.2 at optimal PCR program. Multiple weak bands for sdrD 
PCR product from strains nr.5 and nr.13 and strong multiple bands for the remaining strains 
was obtained in addition to single band.  
 
 
Figure 13: An image of 1% agarose gel showing the result of SdrD-700 PCR for S. aureus 
strain nr.1 to 20(from left to right), molecular weight standard (1Kb plus), in Lane “1” strain 
nr.1, lane “2” strain nr.2 and so on. Lane “P” S. aureus strain NCTC8325 for positive control 
and Lane “N” negative sample that contain water instead of DNA template. 
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 SdrD-700 PCR product from strains nr.21 to 51 gave one single band. This is illustrated in 
Figure 14 and figure 15. The size of band was around 850 bp. The expected size of SdrD-700 
PCR product was approximately 765 bp. 
 
 
Figure 14: An image of 1% agarose gel showing the result of SdrD-700 PCR for S. aureus 
strain nr.21 to 36(from left to right), molecular weight standard (1Kb plus), in Lane “21” 
strain nr.21.lane “22” strain nr.22 and so on. Lane “P” S. aureus strain NCTC8325 for 
positive control and Lane “N” negative sample that contain water instead of DNA template. 
 
 
Figure 15: An image of 1% agarose gel showing the result of SdrD-700 PCR for S. aureus 
strain nr.37 to 51(from left to right), molecular weight standard (1Kb plus), in Lane “37” 
strain nr.37, lane “38 ” strain nr.38 and so on. Lane “P” S. aureus strain NCTC8325 for 
positive control and Lane “N” negative sample that contain water instead of DNA template. 
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SdrD-800 PCR product 
 
As it shown in Figure 16 sdrD-800 PCR product from strain nr.1 to 20, strain nr.2 (lane 2) did 
not gave a product and positive control (lane P) gave a very weak band at optimal PCR 
program. SdrD-800 PCR product from strain nr 3, 5,9,13 and 16 gave one single band at a 
size 850bp and rest of the strains gave additional weak multiple bands. While one single band 
at a size 840 bp was the expected band. 
 
 
Figure 16: An image of 1% agarose gel showing the result of SdrD-800 PCR for S. aureus 
strain nr.1 to 20(from left to right), molecular weight standard (1Kb plus), in Lane “1” strain 
nr.1, lane “2” strain nr.2 and so on. Lane “P” S. aureus strain NCTC8325 for positive control 
and Lane “N” negative sample that contain water instead of DNA template 
 
SdrD-800 PCR product from DNA strain nr.21 to 51 gave one single band around at a size 
850bp, whereby it was expected band at 840 bp for SdrD-800 PCR product (see Figure 17 and 
figure 18). 
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Figure 17: An image of 1% agarose gel showing the result of SdrD-800 PCR for S. aureus 
strain nr.21 to 36(from left to right), molecular weight standard (1Kb plus), in Lane “21” 
strain nr.21, lane “22” strain nr.22 and so on. Lane “P” S. aureus strain NCTC8325 for 
positive control and Lane “N” negative sample that contain water instead of DNA template. 
 
Figure 18: An image of 1% agarose gel showing the result of SdrD-800 PCR for S. aureus 
strain nr.37 to 51(from left to right), molecular weight standard (1Kb plus), in Lane “37” 
strain nr.37, lane “38” strain nr.38 and so on. Lane “P” S. aureus strain NCTC8325 for 
positive reference and Lane “N” negative sample that contain water instead of DNA template. 
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5.4 SdrD Sequence variation 
 
sdrD A-region from all S. aureus strains (strain nr.1-51) were successfully sequenced, except 
from Strain nr.40. A total of 50 S. aureus sdrD-A-region sequences were aligned. Strain nr.40 
was excluded from study because of the sequence was showed poor quality. The identities of 
sequence were checked on BLAST and sequence alignment was performed with BioEdit.  
 
The sdrD-A-region variants classified into 6 groups on the basis of multiple sequence 
alignment (Table 14), but because of high identity similarity between SdrD1 & SdrD2 and 
SdrD4 & SdrD6 (Table 15), the phylogenic tree divided the variants in 4 main groups (Figure 
19 & 20).  
 
Figure 19: Maximum likelihood tree shows phylogenetic relationship among sdrD1-sdrD6 
variants in selected S. aureus strains. Based on DNA sequence alignment. Bootstrap values 
shown on branches. Scale bar represents number of nucleotide changes 
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Figure 20; Maximum likelihood tree shows phylogenetic relationship among sdrD1-sdrD6 
variants in selected S. aureus strains. Based on amino acids sequence alignment. Bootstrap 
values shown on branches. Scale bar represents number of nucleotide changes.  
 
 
As shown in Table 14, the alignment results of sdrD-A-region DNA and amino acids identity 
indicated that there were allelic variations in sdrD-A-region. 
 
Eleven strains (strains nr.1, 11, 18, 28, 29, 32, 33, 34, 37, 38, and 45) had the SdrD1variant. 
Fourteen strains (strains nr. 12, 14, 15, 17, 19, 23, 24, 26, 31, 41, 47, 48, 50, and 51) 
contained SdrD2. Seven strains (strains nr. 4, 8, 13, 20, 25, 35, and 36) had SdrD3. Five 
strains (strains nr. 3, 9, 16, 44, and 46) contained SdrD4. Eleven strains (strains nr. 2, 5, 6, 7, 
10, 21, 22, 27, 30, 39, and 42) had SdrD5 and lastly two strains (strains nr. 43, and 49) were 
included in SdrD6. 
 
The SdrD1 shared 99.4% DNA sequence identity and 98.4% amino acids sequence identity 
with MRSA strain N315.The SdrD2 shared 99.8% DNA sequence identity and 99.6% amino 
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acids sequence identity with the MRSA strain N315. The SdrD3 shared 99.9% and 99.7% 
DNA sequence identity and shared 99.6% and 99.2% amino acids sequence identity with 
those MSSA strain Newman and NCTC8325, respectively. (Table 14) 
The SdrD4 shared 100% DNA sequence identity and 99,8% amino acids sequence identity 
with MRSA strain Ho 5096 0412. The SdrD5 shared 99.8% DNA sequence identity and 
99.4% amino acids sequence identity with MRSA strain MW2 and MSSA strain MSSA476. 
The SdrD-A region for SdrD6 shared 98.7% DNA sequence identity and 98% amino acids 
sequence identity with the MRSA strain Ho 5096 0412. (Table 14)  
 
The highest identity similarity within sequenced isolates was between SdrD1 and SdrD2 
(99.6%) and between SdrD4 and SdrD6 (98.7%) .The smallest Similarities were between 
SdrD2 and SdrD5 (87.4%) (Table15). 
Table 14 shows, the SdrD-A-region variation of DNA and amino acid sequence identity of 
sequenced isolates compared with different reference strains. In Table 15, the SdrD-A-region 
DNA sequence similarity of sequenced isolates to each other was indicated. The alignment 
result of SdrD-A-region DNA variation with different reference strains is shown in Appendix 
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GROUPS SdrD1 SdrD2 SdrD3 SdrD4 SdrD5 SdrD6 
NCTC8325 DNA level 89.0 88.9 99.7 91.0 97.6  89.9 
Amino acids level 86.3 86.2 99.2 90.0 96.6 88.4 
N315 DNA level 99.4 99.8 88.9 87.3 87.1 87.4 
Amino acids level 98.4 99.6 85.9 85.5 84.5 86.3 
Ho50960412 DNA level 87.6 87.4 91.2 100 90.8 98.7 
Amino acids level 86.0 85.8 90.2 99.8 89.4 98.0 
MW2 DNA level 87.4 87.2 97.7 90.6 99.8 89.6 
Amino acids level 85.2 84.8 96.8 89.2 99.4 88.0 
MSSA476 DNA level 87.6 87.3 97.8 90.6 99.8 89.6 
Amino acids level 85.4 84.8 97.0 89.2 99.4 88.0 
Newman DNA level 89.2 89.1 99.9 91.2 97.8 90.0 
Amino acids level 86.6 86.4 99.6 90.4 97.0 88.8 
Table 15: The percentages identity similarities of sdrD variants in DNA level within groups 
 SdrD1 SdrD2 SdrD3 SdrD4 SdrD5 SdrD6 
SdrD1 100 99.6 89.2 87.6 87.6 87.6 
SdrD2 99.6 100 89.0 87.5 87.4 87.6 
SdrD3 89.2 89.0 100 87.6 87.6 87.6 
SdrD4 87.6 87.5 87.6 100 90.8 98.7 
SdrD5 87.6 87.4 87.6 90.8 100 89.8 
SdrD6 87.6 87.6 87.6 98.7 89.8 100 
 
SdrD1= strain nr.1, 11, 18, 28, 29, 32, 33, 34, 37, 38, 45 
SdrD2= strain nr. 12, 14, 15, 17, 19, 23, 24, 26, 31, 41, 47, 48, 50, 51 
SdrD3= strain nr. 4, 8, 13, 20, 25, 35, 36  
SdrD4= strain nr. 3, 9, 16, 44, 46 
SdrD5= strain nr. 2, 5, 6, 7, 10, 21, 22, 27, 30, 39, 42 
SdrD6= strain nr. 43, 
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5.5 Cloning 
	  
To determine the role of sdrD variants in adhesion, adhesion assays will be performed with L. 
lactis.  This required cloning of sdrD variants in a plasmid that can be expressed in L. lactis. 
Strain nr.32 was picked as representative for sdrD1. The full-length sdrD was amplified and 
cloned in plasmid PMG36e and then transformed into L. lactis by electro-transformation.  
 
Insert preparation 
Isolation of genomic DNA for stain nr.32 was done as described under “method”. Full-length 
sdrD PCR was performed (Table 8). The PCR product was checked on 1 % agarose gel and 
gave single strong band between 3kb and 4kb (Figure 21). Whereas the band was expected at 
size 3.4 kb. The PCR product was purified from the gel and the concentration was measured. 
The concentration obtained was 18.4ng/µl and the purity ratio (260/280) was 1.84 (data not 
shown).  
 
Figure 21: An image illustrated the PCR product of sdrD full length 3447 bp. Molecular 
weight standard (1Kb plus) used as marker. 
 
The purified sdrD full length PCR product was used to perform SacI and SphI enzyme 
digestion (see 4.3.1). The product was checked again on 1% agarose gel after restriction 
enzyme digestion for specificity.  The result showed a single bright band in between 3kb and 
4kb (Figure 22) and the product was used for ligation (Table 9). 





Figure 22: 1% agarose gel shows, molecular weight standard (1Kb plus), strain 32 after 
purification and restriction (SacI and SphI) enzyme digested. 
 
Preparation of plasmid pMG36e:SdrDNCTC8325 
 
The first strategy was to cut out sdrD_NCTC8325 from the plasmid pMG36e (Figure 4) and 
replaced with sdrD1 (strain nr.32). Isolation of plasmid from L. lactis was done as described 
under “method” and the concentration was measured.  
The concentration was 161ng/µl and the purity (260/280) ratio was 2.03. The product 
(pMG36e:SdrDNCTC8325) was XbaI and XhoI enzyme digested (see procedure 4.3.2) and 
checked on 1% agarose gel.  
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Figure 23: 1% agarose gel illustrated the result of pMG36e:SdrDNCTC8325 isolated from L. 
lactis after enzyme digest. Molecular weight standard (1Kb plus), lane A 
pMG36e:SdrDNCTC8325 digested by enzyme XbaI and XhoI. Lane B 
pMG36e:SdrDNCTC8325 digested only by enzyme XbaI and Lane C 
pMG36e:SdrDNCTC8325 digested only by enzyme XhoI. 
 
As shown in Figure 23, the result of restriction enzyme digestion showed a smear band. Two 
single bright bands were actually expected at 3.6kb for pMG36e and at 4kb for 
SdrD_NCTC8325.  
The plasmid DNA pMG36e:SdrDNCTC8325 (plasmid isolated from L. lactis) was used to 
transform into E. coli, but no colonies were obtained. The transformation and the restriction 
enzyme digestion failed.  
Therefore the preparation of vector pMG36e:SdrDNCTC8325 was stopped and the 
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Preparation of plasmid pMG36e 
 
Restriction enzyme digest for pMG36e:SdrDNCTC8325 plasmid isolated from L. lactis and 
transformation of plasmid pMG36e:SdrDNCTC8325 into E. coli did not gave the result. 
Therefore, an alternative strategy was applied. That is using empty pMG36e plasmid (Figure 
5). Plasmid isolation from L. lactis was done and the concentration was measured.  
 
The concentration was 187ng/µl and the purity (260/280) ratio was 2.01. The product 
(pMG36e) that was isolated from L. lactis was SacI and SphI enzyme digested (see procedure 
on 4.3.2) and checked on 1% agarose gel. The result showed two single bands at 2 kb and 4 




Figure 24: 1% agarose gel; molecular weight standard (1Kb plus), the result of pMG36e 
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solation of plasmid from E. coli 
 
The restriction enzyme digestion of pMG36e isolated from L. lactis result showed two single 
bands at 2 kb and 4 kb (Figure 24). Even though expected result was a single bright band at 
3.6kb for pMG36e.  
To investigate this further the L. lactis DNA containing plasmid pMG36e was transformed 
into E. coli. Transformation of plasmid pMG36e into E. coli gave several colonies. The 
plasmid pMG36e was isolated from E. coli and the concentration was measured.  
The concentration of plasmid pMG36e isolated from E. coli was 938.3ng/µl and purity 
(260/280) ratio was 2.15.  
E. coli DNA containing plasmid pMG36e was SacI and SphI enzyme digested (see procedure 
on 4.3.2) and was checked on 1 % agarose gel. The result showed a single band at in between 
3kb and 4kb as expected (Figure 25).  
The product was purified from agarose gel and the concentration measured. The concentration 
after purification was 84.5ng/µl and purity (260/280) ratio was 2.04. This product was 
purified from gel for further use in ligation (Table 9). 
 
 
Figure 25: 1% agarose gel; molecular weight standard (1Kb plus), the result of vector 
pMG36e after restriction enzyme (SacI and SphI) digested. 
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Transformation of Ligation mix (pMG36e + SdrD1) into E. coli 
 
SdrD1 insert that was purified and restriction enzyme (SacI and SphI) digested and plasmid 
(pMG36e) isolated from E. coli, restriction enzyme (SacI and SphI) digested and purified 
were used in a ligation mix. Ligation mix was transformed into E. coli.  
 
Transformation was done with three different vector:insert ratio (see Table 9 for details ). 
The transformation of ligation mix was successful. All of the three different vector insert 
ratios (1:1, 1:3 and 1:10) gave a good number of colonies. Twelve colonies from 1:3 ratio-
plate screened for the right insert (see procedure on 4.3.4).  
Nine colonies were SdrD positive; one colony gave double band (lane 7) and eight colonies 
gave single band at 4kb the result illustrated in Figure 25.  
The constructs were verified by sequencing. The sequencing result showed that five (colony 




Figure 26: 1% agarose gel, molecular weight standard (1Kb plus), picture illustrating the 
result of colonies screening. Lane P, positive control. 
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5.6 Electro-transformation of pMG36e:sdrD1 into L. lactis 
 
An adhesion assays will be performed with L. lactis + sdrD from NCTC8325, L. lactis 
+sdrD1 and L. lactis without SdrD, while we have the constructed plasmid in E. coli. Since E. 
coli is a gram-negative bacterium, it cannot use as surrogate bacteria. Therefore transferring 
of constructed plasmid (pMG36e:SdrD1) from E. coli into L. lactis was necessary.  
In this step, attempts were made to transform pMG36e:SdrD1 from E. coli into L. lactis by 
electro-transformation. Two colonies were recovered on a selective media and plasmid 
isolation was performed. The product was screened for the right insert (see procedure on 
4.3.4).  
Regardless of the successful transformation into E. coli, both obtained trans-formants were 
sdrD1 insert (strain nr.32) negative after electro-transformation. The expected band at a size 
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6.  Discussion 
 
DNA from a total of 51 S. aureus strains was isolated, and the A-region of sdrD was 
amplified, purified and the products were sequenced. The identity of the sequence was 
checked using BLAST and the sequences were aligned using BioEdit program.  
To investigate adhesion ability of variants, the full-length SdrD1 variant was cloned into a 
shuttle vector and transformed into E. coli, thereafter into L. lactis.  
 
According to the European Centre for Disease Prevention and Control (ECDC) S. aureus 
caused 21.5 % of surgical site, 11.4 % of bloodstream infections in hospitalized patients (Zarb 
et al., 2012). In addition data that is collected from 23 countries showed the percentage of 
MRSA infection was 34.2 % (Zarb et al., 2012). This demonstrates the importance of 
increased understanding of the molecular aspects of interaction between S. aureus and host 
cells. 
The crucial steps for the colonization and survival of bacteria depend on the ability to adhere 
and invade cells. Decolonization of S. aureus carriers might reduce postoperative 
staphylococcal infections. (Ten Broeke-Smits et al., 2010) 
Bacterial surface proteins MSCRAMMs are important for adherence (Josefsson et al., 1998). 
SdrD, a MSCRAMMs family protein plays an important role in S. aureus adhesion and 
pathogenesis, but not essential for bacterial survival (Xue et al., 2011). A recent report noted 
that sdrD is associated with MRSA strains (Sabat et al., 2006, Paniagua-Contreras et al., 
2014).  
The study of MSCRAMMS can lead to the development of several potentially efficacious 
immunological therapeutic and prophylactic strategies to control S. aureus (Flock, 1999).  
It assumed that the A domain of SdrD interact with host protein which is not yet identified 
(Josefsson et al., 1998). There are indications that SdrD can interact with relevant human 
proteins (unpublished results, HMI research group).  
The surface adhesion proteins varies among S. aureus isolates (McCarthy and Lindsay, 
2010).There may be allelic variation in SdrD that either improve or reduce its binding to host 
cells. For this purpose, we investigated the allelic variation of SdrD-A-region. Our results 
show that there is allelic variation in SdrD-A-region. 
	   60	  
 “The great number of nucleotide differences is a general characteristic of cell surface genes 
in S. aureus” (Kuhn et al., 2006). In this study Khun et al demonstrate the comparison of 
allelic and nucleotide divergence between conserved genes and adhesions genes of S. aureus. 
The gene diversity of adhesions genes was 10 times greater than conserved gene, and 
concluded the variation might be due to evolution results from gene recombination (Kuhn et 
al., 2006).  
There are four sources of genetic variation. Spontaneous mutations, that results from errors, 
mistakes, accidents, and lesions. These can happen due to DNA replication or internal or 
external environmental influence. (Arber, 1995) 
DNA recombination between slightly different genetic information brings a large variety in 
individual genome composition. DNA rearrangement cause genetic variation. (Arber, 1995) 
Horizontal gene transformation (HGT) refers to the transfer of genes between organisms in a 
manner other than traditional reproduction. Many clinically important bacteria acquire 
virulence factor and antibiotic resistance through HGT. (Arber, 1995) 
 
A few DNA sequence alterations bring a selective advantage to the organism, while many 
more sequence alterations cause a selective disadvantage or, in the extreme case, lethality 
(Arber, 1995). This rule indicates that, in general spontaneous genetic variations are not in 
response to a specific need of an organism in its environment.  
A major question still remains to be answered, whether this variation is due to insertion, 
deletion, mutation or horizontal gene transformation.  
The mechanism of how the sdrD-A-region variation happened is still unknown and it is not 
the aim of the study. Our concern is if variation contributes for ligand binding ability. If not 
why the bacteria used energy to change a DNA sequence, which is lead to amino acids 
sequence change? There are a lot of hypothesis that can arise from this result. But this study is 
the start and leads too many hypotheses that would be answer in future. “This is not the end, 
this is not even the beginning of the end, but it is perhaps the end of the beginning” Winston 
Churchill. 
Our results show that there is allelic variation in SdrD-A-region. Similar finding was reported 
previously. A previous study reported several insertion and deletion mutation in the A-region 
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of SdrC, SdrD and SdrE. The DNA sequence identity of SdrD A-region among S. aureus 
isolated from different region shared 99.15% and B- repeats shared 99.84%. (Xue et al., 2011) 
Xue et al analyzed the full-length of Sdr-families. In our study, the analyzed was done only 
on A-region of sdrD, because it presumed the A-region of sdrD that interact with host cells. 
The variation in the other region might be affecting the outcome of adhesion study. This can 
be restricted when the adhesion study will be done in S. aureus. In S. aureus it is possible to 
do knockout of the other region and figure out only the contribution of sdrD A- region. 
  
Xue et al reported that, there is allelic variation in B-region of sdrD (Xue et al., 2011). 
Moreover it is described that the B-domain of Sdr-family protein SdrF in S. epidermis was 
involved in adhesion (Arrecubieta et al., 2007). If the assumption of A-region interact with 
host cell is not true, the variation in B-region of sdrD can affect the outcome of study. 
 
It is possible that variation in some surface protein has resulted in altered ligand binding 
affinity. The FnBPB proteins show a high degree of variance. However the ligand binding 
seems to be unchanged (Burke et al., 2010).  
On the other hand variation in FnBPA is associated with varying ligand-binding affinities 
(Loughman et al., 2008). These suggest variation in sdrD can result with altering ligand 
binding or not. If variation alters ligand binding, what are the consequences of this? 
The new strategies aiming at controlling of virulence factors, to weaken bacteria without 
directly killing them is to develop efficacious vaccine (Papa et al., 2013). Understanding the 
role of allelic variation may help to identify failure of previous S. aureus vaccines. The 
inclusions of multiple allelic antigens probably result in a more effective vaccine. There is a 
possibility that “one size hat doesn’t fit all”. All vaccines tested and failed in clinical trials not 
take to account the allelic variation.  
 
If variation alters ligand binding, it means some variants bind stronger than other; it will be 
hard to remove these variants. This means treatment for weak binding variants can’t work for 
strong binding variants. To develop efficacious vaccines, there is a need to understand the role 
of allelic variation in virulence factor of S. aureus.  
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Despite of the complexity of S. aureus and its myriad virulence factors, with deep knowledge 
of the critical determinants of S. aureus virulence factor, for example with including variant 
antigen in vaccine, it is not an unattainable task; there is a hope to develop successful S. 
aureus vaccine in clinical trial. 
If sdrD A-region variations not alter ligand binding, what it means? This suggests that the 
variations are the result of insertion deletion and shows the instability of the SdrD protein. 
This leads to engaging SdrD as vaccine antigen doubtful. Because instable proteins are not a 
good antigen (Foster and Hook, 1999).  
 
If variations not alter ligand binding, it may affect bacterial condition of infection. MRSA 
share a common genetic background with MSSA and the success of MRSA is due to extrinsic 
and genetic determinants of the bacterium (Hallin et al., 2008).  
We found sdrD A-region sequence from MSSA strains that match with MRSA strains sdrD 
A-region reported in GenBank. The MSSA sdrD identity matching with MRSA strains 
probably the precondition of S. aureus evolution or it is due to environmental and host factor 
stress. This might be affecting the outcome of infection. 
 
Interestingly an association between sdrD-A region variation and Spa type was observed in 
our study. Spa typing is a typing method for S. aureus, based on sequencing of a single 
polymorphic variable-number tandem repeat (VNTR) region of the S. aureus protein-A gene 
(Sangvik et al., 2011).  
In Tromsø 6 study the second most common spa type was t084, CC084 (7.6%) (Sangvik et 
al., 2011). In our study the SdrD1 variant seemed to be associated with CC084, SdrD3 with 
CC24, SdrD4 with CC5, and SdrD5 with CC78. Except for SdrD2 variant that belonged to 
different clonal complex (CC2 and CC84). Based on this, one could speculate that may be 
every clonal complex have own SdrD type. 
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One factor that is not taken into account in this study is the possibility of sequencing error. 
The majority of strains are sequenced once but a few strains are sequenced twice. Since both 
strands were sequenced bidirectional, the probability of sequencing error was very little and 
the results are repeatable.  
PCR 
In order to found out the allelic variation in sdrD A-region, it was necessary to do PCR and 
sequencing. For this aim, it was important to optimize the PCR. Two control strains, S. aureus 
strain MSSA476 and NCTC8325 were used to optimize PCR. 
 
Under optimization of annealing temperature in the gradient PCR strain NCTC8325 gave 
single band at 60.4 °C, strain MSSA476 gave multiple bands at this temperature (see Figure 
11 and 12). This could be due to the difference of the concentration of DNA or could be the 
strains characteristic is different, or both reasons were contribute to the observed difference. 
The concentration was almost four times higher for DNA from strain MSSA476 (99.46ng/µl) 
than DNA from strain NCTC8325 (24.46ng/µl). 
 
There was also an unexpected event during optimization of annealing temperature. According 
to the theory of PCR, when the temperature (50°C) is reduced under the melting point of 
primers, the primer may bind non-specifically and non-specific bands seen on a gel. In this 
case this principle wasn’t occurring. The band was weak single band in low temperature (see 
figure 11). 
 
After optimization was done, PCR for DNA from the first 20 S. aureus isolates from Tromsø 
6 study was done. For both PCR (sdrD-700 & sdrD-800), most strains were revealed multiple 
bands in addition to single band at a right size (see figure 13 & 16). In spite of multiple bands 
on 1% agarose gel, strains were gave legible sequence result. The reason of this problem was 
unknown until we were started to use new batch “reddymix” for DNA from the next 31 S. 
aureus isolates from Tromsø 6. 
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The same DNA template gave a good gel picture after changing “Reddymix” (new batch). 
The product was from the same manufacturer; the only difference was manufacturing day and 
different batch number.  
 
Cloning 
Because S. aureus expresses different combination of surface proteins, it is difficult to figure 
out the contribution of single protein. This approach was complemented by the expression of 
SdrD protein separately on the surface of the surrogate gram-positive bacterium L. lactis.  
The expression of sdrD A-region on the surface of L. lactis was impossible due to the lack of 
signal sequence, cell wall-spaning segment and membrane spanning region. As a result full-
length sdrD was cloned in shuttle plasmid.   
 
The adhesion method was based on previous study (Barbu et al., 2010, Kintarak et al., 2004). 
The principle is to let L. lactis with PMG36e:SdrD1, L. lactis with PMG36e, and L. lactis 
without plasmid adhere with HEK293 cells, which is transfected with labeled eukaryotic 
partner proteins, and un-transfected cells. Then determine the difference in adherence.  
 
To do adhesion assay, cloning should be performed. Full SdrD was amplified and cloned in 
plasmid pMG36e and transformed into L. lactis by electro-transformation.  
The first strategy was to cut out sdrD-NCTC8325 from the plasmid 
pMG36e:sdrD_NCTC8325 (see figure 4) and substituted that with one of sdrD variant. 
Neither restriction enzyme digestion nor transformation into E. coli was successful. 
Restriction enzyme cut result was not effective (see figure 23) and transformation didn’t yield 
any transformants.  
 
Unsuccessful transformation into E. coli was unexpected, as this method (standard 
transformation method) has been found to efficiently introduce plasmid DNA into E. coli.  
In principle, shuttle plasmid can be moved back and forth between different hosts (Griffiths et 
al., 1999).  
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E. coli competent cells used in this experiment were found to be good quality and that the 
positive control which included in the experiment was illustrated that the method also worked 
efficiently.  
The restriction enzymes were tested for effectiveness by using another plasmid DNA (not 
mentioned under method) and the enzymes were adequate. Isolation method works on the 
same plasmid DNA without sdrD and the method was good enough. This led to the 
assumption that the lack of success with the experiment could be pMG36e:SdrDNCTC8325. 
But what it could be? Maybe the plasmid prepared to use as it is, or some modification done 
by L. lactis? 
 
Because of these problems the strategy was changed. The second strategy was to use pMG36e 
without sdrD (see figure 5). Restriction enzyme digestion on this plasmid also failed (see 
figure 24), but transformation into E. coli succeeded. 
The possible explanation for unsuccessful enzyme digestion on plasmid can be genetic 
modification was done by L. lactis that make a recognition sequence unrecognized for 
restriction enzymes, most probably methylation? 
 
Electro-transformation  
Before we could start the adhesion assays transferring of constructed plasmid from E. coli 
into L. lactis was required. This was done with electro transformation. Electro-transformation 
of construct plasmid into L. lactis was failed.  
 
Despite of the successful construct and transformation into E. coli with standard method, the 
colony obtained after electro-transformation was negative and the adhesion study could not be 
continued.  
Electro transformation and preparation of electro competent cells was done twice without 
success. In the second attempt, the transformation was done with different plasmid DNA 
concentration and didn’t work.  
 
The limitation under electro-transformation was the positive and negative controls weren’t 
included in the experiment. Without appropriate positive and negative controls for 
transformation reactions, it was very difficult to evaluate the problem was in preparation of 
electro competent cells, efficiency of competent cells or transformation process. 
	   66	  
Troubleshooting was virtually impossible without any controls. Because of time limit the 
experiment was not repeated; no investigation was done to figure out the possible 
explanation.  
It could be in electro-competent cell preparing steps, L. lactis strain M1363 was not grow fast 
to the OD which is necessary to get best result, and freezing step with liquid hydrogen or dry 
ice/ethanol was not performed.  
L. lactis strain M1363 took 10 hours to grow to appropriate OD, whereas expected time was 4 
hours. It is recommended that the fast growing cells usually give the best result and the 













	   67	  
7. Conclusion and future study 
 
There is allelic variation in A-region of SdrD. For further study of adhesions, the constructs 
(pMG36e:SdrD1 in E. coli) was prepared, and constructing of the other variants is ongoing in 
the laboratory of HMI research group.  
For further research a test should be done to assure if variation can alter ligand binding 
affinity or not, if it alters binding affinity what is the consequence of that? It is important to 
consider how much divergence is required for variants to function differently. It is also 
important to find out if there is variation in other regions of sdrD, and if they can affect the 
adhesion study. These questions need further investigation before “engaging” SdrD for future 
therapy target. It is very important to address future studies to determine the pathogenic 
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Appendices 
Appendix 1: Overview of bacteria isolate  
IDa T6b ID spa 
type 
CCc ID T6 ID spa 
type 
CC 
1 61010014 t084 84 27 61010179 t5257 78 
2 61010019 t5449 78 28 61010180 t084 84 
3 61010021 t223 5 29 61010202 t084 84 
4 61010026 t305 24 30 61010206 t814 78 
5 61010037 t759 78 31 61010209 t2119 84 
6 61010045 t167 78 32 61010210 t084 84 
7 61010051 t349 78 33 61010213 t084 84 
8 61010060 t024 24 34 61010217 t084 84 
9 61010103 t3610 S 35 61010218 t024 24 
10 61010105 t1102 78 36 61010221 t024 24 
11 61010109 t084 84 37 61010227 t084 84 
12 61010111 t601 2 38 61010228 t094 84 
13 61010112 t1476 24 39 61010231 t280 78 
14 61010116 t045 2 40 61010245 t2103 153 
15 61010122 t002 2 41 61010247 t084 84 
16 61010128 t005 5 42 61010261 t078 78 
17 61010132 t581 2 43 61010268 t209 65 
18 61010135 t5232 84 44 61010269 t309 5 
19 61010136 t002 2 45 61010280  
20 61010146 t008 24 46 61010301 t005 5 
21 61010150 t528 E 47 61010302 t084 84 
22 61010164 t1102 78 48 61010303 t084 84 
23 61010165 t084 84 49 61010305 t186 S 
24 61010168 t4173 267 50 61010307 t084 84 
25 61010169 t008 24 51 61010309 t548 2 
26 61010173 t5423 2     
a= Strain ID in thesis 
b= Tromsø 6 study ID 
c= clonal complex  
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Appendix 3: Buffer and reagent Composition 
 
1x ReddyMix  
0,625 units   ThermoPrime Taq DNA polymerase 
75mM   Tris-HCL (pH 8,8) 
20mM   (NH4 )2SO4 
1,5mM             MgCl2 
0,01%(v/v)  Tween 20 
0,2mM each of dATP, dCTP, dGTP, dTTP 
Precipitant and red dye for electrophoresis 
 
TE-Buffer pH: 1x  
10mM       Tris-Hcl pH: 8 
 0,5M         EDTA  
 
TAE-buffer 1x  
40mM  Tris-Hcl (Trizma –base) 
 20mM acetic acid 
1mM   EDTA pH:8 
  
 
1x NEBuffer 4: 
50 mM        Potassium acetate 
20mM          Tris acetate 
10 mM        Magnesium acetate 
1mM          DTT pH 7.9 
 
SGM17-Gly medium  
0.5MSucrose + 0.5% Glucose + 2.5%glycine 
SGM17-medium with 10µg/ml erythromycin 
0.5% Sucrose + 0.4% glucose +10µg/ml 
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Electrotransformation solution (ES)  
30% Polethyleneglycol + 10%glycerol + 
double distilled water 
 
Washing Solution  
0.5M Sucrose +10%glycerol + double distilled 
water 
 
BSA (Bovine Serum Albumin) 10x 
2mM              KPO4 (pH 7.0 at 25°C),  
5 mM              NaCl 
0.01 mM          EDTA  
 0.5%              Glycerol. 
 
Lysogenic Broth (Luria broth) 
 
1.0 %       Tryptone 
0.5 %       Yeast extract 
1.0 %       Sodium chloride 
400µg/ml    Erythromycin 
SOC 
0.5%     Yeast 
2%      Tryptone 
10mM  NaCl 
2.5mM  KCl 
20mM   Glucose 
10mM   MgCl2 
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Appendix 4: Variation in DNA level 
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Appendix 5: variation in Amino acids level 
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